Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT05489393
Eligibility Criteria:
Inclusion Criteria:
* Individuals of all ages with a self-reported diagnosis of DRPLA.
* Understand and sign the informed consent form (IFC). Participants who lack the capacity to consent (e.g. cognitively impaired individuals) will require consent from the legal authorized representative, and the assent of the subject will be obtained to the extent compatible with their capacity. Participants at age 12 to age of consent will require assent along with the consent of their parent or legal guardian.
Exclusion Criteria:
* Ataxia conditions other than DRPLA.
* Failure to sign the IFC (and assent form, as needed).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
100 Years
Study:
NCT05489393
Study Brief:
Protocol Section:
NCT05489393